Inhibitor Therapeutics (INTI) Stock Chart & Stock Price History $0.05 +0.01 (+30.18%) As of 09/5/2025 03:11 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Inhibitor Therapeutics Stock Price Performance The Inhibitor Therapeutics (INTI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 28.12%, with a year-to-date return of -17.47%. In the past month, the stock has increased 20.98%, reflecting recent market activity. As of the latest close, Inhibitor Therapeutics traded at $0.05 with a market cap of $8.56 million and volume of 1,500 shares. Five years ago, the stock traded at $0.05, representing a 5.52% decrease over that period. At the time, it had a market cap of $20.85 million and a volume of 10,000 shares. Receive INTI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+12.22%1 Month Performance+20.98%3 Month Performance-8.15%Year-To-Date Performance-17.47%1 Year Performance-28.12%5 Year Performance-5.52% INTI Stock Chart for Monday, September, 8, 2025 INTI Chart by TradingView Inhibitor Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/05/2025$0.04$0.05+30.18%$0.05$0.051,500 shs$8.56 million09/04/2025$0.04$0.04-13.80%$0.06$0.0415,625 shs$6.58 million09/03/2025$0.04$0.04$0.04$0.0410,000 shs$7.63 million09/02/2025$0.04$0.04$0.04$0.0410,000 shs$7.63 million09/01/2025$0.04$0.04$0.04$0.0410,000 shs$7.63 million08/29/2025$0.06$0.04-23.66%$0.04$0.0410,000 shs$7.63 million08/28/2025$0.06$0.06$0.06$0.066,138 shs$9.99 million08/27/2025$0.06$0.06$0.06$0.062,080 shs$9.99 million08/26/2025$0.06$0.06$0.06$0.062,080 shs$9.99 million08/25/2025$0.06$0.06$0.06$0.062,900 shs$9.99 million Get the Latest News and Ratings for INTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/22/2025$0.06$0.06$0.06$0.066,000 shs$9.99 million08/21/2025$0.05$0.06+12.21%$0.06$0.06400 shs$9.99 million08/20/2025$0.05$0.05$0.06$0.0416,000 shs$8.91 million08/19/2025$0.04$0.05+22.86%$0.06$0.0416,000 shs$8.91 million08/18/2025$0.04$0.04+5.00%$0.04$0.0448,000 shs$7.25 million08/15/2025$0.04$0.04+2.30%$0.05$0.04162,520 shs$6.90 million08/14/2025$0.05$0.04-20.20%$0.04$0.0412,000 shs$6.75 million08/13/2025$0.05$0.05$0.05$0.0511,600 shs$8.46 million08/12/2025$0.04$0.05+19.51%$0.05$0.0511,600 shs$8.46 million08/11/2025$0.04$0.04$0.05$0.0428,650 shs$7.08 million08/08/2025$0.05$0.04-12.77%$0.05$0.0428,650 shs$7.08 million08/07/2025$0.05$0.05-9.44%$0.05$0.044,975 shs$8.11 million Related Companies Mersana Therapeutics Stock Chart Medicus Pharma Stock Chart Dyadic International Stock Chart Neoleukin Therapeutics Stock Chart HedgePath Pharmaceuticals Stock Chart ImageneBio Stock Chart Iterum Therapeutics Stock Chart BioAtla Stock Chart Rein Therapeutics Stock Chart Provectus Biopharmaceuticals Stock Chart Receive INTI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:INTI) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibitor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibitor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INTI Stock Alerts